Arrivent Biopharma Inc (AVBP)

Mar 30, 2025

Swiss National Bank Buys Shares of 26,400 ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Mar 30, 2025

Mar 26, 2025

Charles Schwab Investment Management Inc. Has $5.50 Million Stake in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Mar 26, 2025

Mar 24, 2025

Brokers Offer Predictions for AVBP Q1 Earnings - Defense World

Mar 24, 2025

Mar 23, 2025

Brokerages Set ArriVent BioPharma, Inc. (NASDAQ:AVBP) Target Price at $39.40 - Defense World

Mar 23, 2025

Mar 22, 2025

ArriVent BioPharma (NASDAQ:AVBP) Upgraded at B. Riley - Defense World

Mar 22, 2025

Mar 20, 2025

B.Riley sets $37 target on ArriVent stock, initiates with Buy - Investing.com Canada

Mar 20, 2025

Mar 20, 2025

ArriVent Lead Drug Candidate Shows Promise In Lung Cancer Type, Analyst Sees Over 50% Upside - Benzinga

Mar 20, 2025

Mar 20, 2025

This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Mar 20, 2025

Mar 20, 2025

B. Riley Initiates ArriVent BioPharma at Buy With $37 Price Target -March 20, 2025 at 07:13 am EDT - MarketScreener

Mar 20, 2025

Mar 20, 2025

ArriVent Biopharma initiated with a Buy at B. Riley - TipRanks

Mar 20, 2025

Mar 20, 2025

ArriVent BioPharma (AVBP) Projected to Post Quarterly Earnings on Thursday - Defense World

Mar 20, 2025

Mar 19, 2025

ArriVent BioPharma (AVBP): Among the Best Short Squeeze Stocks to Buy According to Analysts - Insider Monkey

Mar 19, 2025

Mar 19, 2025

10 Best Short Squeeze Stocks to Buy According to Analysts - Insider Monkey

Mar 19, 2025

Mar 17, 2025

ArriVent BioPharma reports FY results - MSN

Mar 17, 2025

Mar 15, 2025

(AVBP) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Mar 15, 2025

Mar 13, 2025

ArriVent BioPharma appoints PwC as new auditor - Investing.com India

Mar 13, 2025

Mar 13, 2025

ArriVent BioPharma appoints PwC as new auditor By Investing.com - Investing.com South Africa

Mar 13, 2025

Mar 11, 2025

ArriVent BioPharma (NASDAQ:AVBP) Now Covered by Analysts at Guggenheim - Defense World

Mar 11, 2025

Mar 10, 2025

Oppenheimer starts ArriVent BioPharma at outperform - MSN

Mar 10, 2025

Mar 10, 2025

Guggenheim starts ArriVent Biopharma with a Buy on firmonertinib potential - TipRanks

Mar 10, 2025

Mar 09, 2025

Financial Contrast: ArriVent BioPharma (AVBP) and The Competition - Defense World

Mar 09, 2025

Mar 09, 2025

ArriVent BioPharma (NASDAQ:AVBP) Earns “Buy” Rating from HC Wainwright - Defense World

Mar 09, 2025

Mar 08, 2025

Here's What Could Help ArriVent BioPharma, Inc. (AVBP) Maintain Its Recent Price Strength - MSN

Mar 08, 2025

Mar 08, 2025

H.C. Wainwright maintains Buy on ArriVent shares, $39 target By Investing.com - Investing.com Canada

Mar 08, 2025

Mar 08, 2025

ArriVent BioPharma Reports 2024 Financial Results and Key Achievements - MSN

Mar 08, 2025

Mar 07, 2025

H.C. Wainwright maintains Buy on ArriVent shares, $39 target - Investing.com India

Mar 07, 2025

Mar 07, 2025

Rhumbline Advisers Purchases 3,069 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Mar 07, 2025

Mar 07, 2025

FY2025 EPS Estimates for AVBP Reduced by Lifesci Capital - Defense World

Mar 07, 2025

Mar 06, 2025

New York State Common Retirement Fund Boosts Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Mar 06, 2025

Mar 04, 2025

ArriVent BioPharma Reports 2024 Financial Results and Progress - MSN

Mar 04, 2025

Mar 04, 2025

(AVBP) Investment Report - Stock Traders Daily

Mar 04, 2025

Mar 04, 2025

Lepu Biopharma Co., Ltd. Announces Update on New Drug Application of MRG003 -March 03, 2025 - Marketscreener.com

Mar 04, 2025

Mar 03, 2025

ArriVent BioPharma, Inc. SEC 10-K Report - TradingView

Mar 03, 2025

Mar 03, 2025

ArriVent BioPharma Reports Full Year 2024 Financial Results - The Manila Times

Mar 03, 2025

Feb 26, 2025

Arbutus Biopharma Appoints Lindsay Androski as CEO Amid Leadership Restructuring - MyChesCo

Feb 26, 2025

Feb 24, 2025

IPOs Numbers Rise In 2024, But Dwindling Returns Could Diminish Potential In 2025 - insights.citeline.com

Feb 24, 2025

Feb 22, 2025

Where are the Opportunities in (AVBP) - Stock Traders Daily

Feb 22, 2025

Feb 19, 2025

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Short Interest Update - MarketBeat

Feb 19, 2025

Feb 16, 2025

Mirae Asset Global Investments Co. Ltd. Makes New Investment in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Feb 16, 2025

Feb 16, 2025

Mirae Asset Global Investments Co. Ltd. Purchases Shares of 1,123 ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Armenian Reporter

Feb 16, 2025

Feb 11, 2025

How To Trade (AVBP) - Stock Traders Daily

Feb 11, 2025

Feb 06, 2025

Short Interest in ArriVent BioPharma, Inc. (NASDAQ:AVBP) Expands By 13.1% - MarketBeat

Feb 06, 2025

Feb 05, 2025

Deal Watch: Novo Nordisk, IMMvention To Partner On Sickle Cell Disease - News & Insights

Feb 05, 2025

Feb 04, 2025

Asia’s NewCo Model, FDA tipping point, Vertex’s pain drug: a BioCentury podcast - biocentury.com

Feb 04, 2025

Jan 31, 2025

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Shares Bought by JPMorgan Chase & Co. - Defense World

Jan 31, 2025

Jan 30, 2025

(AVBP) Trading Signals - Stock Traders Daily

Jan 30, 2025

Jan 29, 2025

The NewCo boom signals China’s galloping speed of innovation - BioCentury

Jan 29, 2025

Jan 28, 2025

Abbvie seeks molecular glue degraders from Neomorph - biocentury.com

Jan 28, 2025

Jan 27, 2025

ArriVent in Newtown Square Sees Big Potential in New Cancer Drug - DELCO.Today

Jan 27, 2025

Jan 27, 2025

ArriVent BioPharma Secures Global Rights to MRG007 in Strategic Deal with Lepu Biopharma - MSN

Jan 27, 2025

Jan 27, 2025

IPO excitement heats up as Metsera targets $1.8B valuation, Aurion joins queue - FirstWord Pharma

Jan 27, 2025

Jan 25, 2025

Equities Analysts Set Expectations for AVBP Q1 Earnings - Defense World

Jan 25, 2025

Jan 24, 2025

HC Wainwright Issues Positive Estimate for AVBP Earnings - MarketBeat

Jan 24, 2025